Xanthine oxidase inhibitors for prevention of cardiovascular events: a systematic review and meta-analysis of randomized controlled trials
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Xanthine oxidase inhibitors for prevention of cardiovascular events: a systematic review and meta-analysis of randomized controlled trials
Authors
Keywords
Gout, Treatment, Cardiovascular disease, Meta-analysis, Xanthine Oxidase inhibitors
Journal
BMC Cardiovascular Disorders
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-02-07
DOI
10.1186/s12872-018-0757-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Allopurinol as a therapeutic option in cardiovascular disease
- (2017) Osita N Okafor et al. PHARMACOLOGY & THERAPEUTICS
- Cardiovascular effects of urate-lowering therapies in patients with chronic gout: a systematic review and meta-analysis
- (2017) Tony Zhang et al. RHEUMATOLOGY
- Urate-lowering therapy for asymptomatic hyperuricaemia: A need for caution
- (2017) Lisa Stamp et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Effect of uric acid-lowering therapy on blood pressure: systematic review and meta-analysis
- (2016) Li-hui Qu et al. ANNALS OF MEDICINE
- Allopurinol and the risk of stroke in older adults receiving medicare
- (2016) Jasvinder A. Singh et al. BMC Neurology
- Allopurinol therapy improves vascular endothelial function in subjects at risk for cardiovascular diseases: a meta-analysis of randomized controlled trials
- (2016) Wei Xin et al. Cardiovascular Therapeutics
- The Impact of Allopurinol on Patients With Acute ST Elevation Myocardial Infarction Undergoing Thrombolytic Therapy
- (2016) Ahmad Separham et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Effects of Allopurinol on Arterial Stiffness: A Meta-Analysis of Randomized Controlled Trials
- (2016) Gang Deng et al. MEDICAL SCIENCE MONITOR
- Allopurinol and Progression of CKD and Cardiovascular Events: Long-term Follow-up of a Randomized Clinical Trial
- (2015) Marian Goicoechea et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Xanthine Oxidase Inhibitors in Heart Failure: Where Do We Go From Here?
- (2015) L. Tamariz et al. CIRCULATION
- Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study
- (2015) M. M. Givertz et al. CIRCULATION
- Allopurinol use and risk of non-fatal acute myocardial infarction
- (2015) Francisco J de Abajo et al. HEART
- Febuxostat improves endothelial function in hemodialysis patients with hyperuricemia: A randomized controlled study
- (2015) Yuki Tsuruta et al. Hemodialysis International
- Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis
- (2015) Tahir Kanji et al. BMC Nephrology
- Effects of Allopurinol on Endothelial Dysfunction: A Meta-Analysis
- (2014) Mehmet Kanbay et al. AMERICAN JOURNAL OF NEPHROLOGY
- Impact of allopurinol on risk of myocardial infarction
- (2014) L Grimaldi-Bensouda et al. ANNALS OF THE RHEUMATIC DISEASES
- Allopurinol initiation and all-cause mortality in the general population
- (2014) Maureen Dubreuil et al. ANNALS OF THE RHEUMATIC DISEASES
- Improving cardiovascular and renal outcomes in gout: what should we target?
- (2014) Pascal Richette et al. Nature Reviews Rheumatology
- Myeloperoxidase and oxidation of uric acid in gout: implications for the clinical consequences of hyperuricaemia
- (2014) L. K. Stamp et al. RHEUMATOLOGY
- Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia
- (2014) T. M. MacDonald et al. BMJ Open
- Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative
- (2013) Francisca Sivera et al. ANNALS OF THE RHEUMATIC DISEASES
- Comparison of Febuxostat and Allopurinol for Hyperuricemia in Cardiac Surgery Patients (NU-FLASH Trial)
- (2013) Akira Sezai et al. CIRCULATION JOURNAL
- Safety profile of anti-gout agents
- (2013) Lisa K. Stamp CURRENT OPINION IN RHEUMATOLOGY
- As compared to allopurinol, urate-lowering therapy with febuxostat has superior effects on oxidative stress and pulse wave velocity in patients with severe chronic tophaceous gout
- (2013) A.-K. Tausche et al. RHEUMATOLOGY INTERNATIONAL
- Starting dose is a risk factor for allopurinol hypersensitivity syndrome: A proposed safe starting dose of allopurinol
- (2012) Lisa K. Stamp et al. ARTHRITIS AND RHEUMATISM
- Changes in Uric Acid Levels and Allopurinol Use in Chronic Heart Failure: Association With Improved Survival
- (2012) Israel Gotsman et al. JOURNAL OF CARDIAC FAILURE
- Effect of Allopurinol on Blood Pressure: A Systematic Review and Meta-Analysis
- (2012) Vikram Agarwal et al. Journal of Clinical Hypertension
- Furosemide increases plasma oxypurinol without lowering serum urate--a complex drug interaction: implications for clinical practice
- (2012) L. K. Stamp et al. RHEUMATOLOGY
- Meta-analysis of incidence of rare events
- (2012) Peter W Lane STATISTICAL METHODS IN MEDICAL RESEARCH
- Xanthine Oxidase Inhibition For The Treatment Of Cardiovascular Disease: A Systematic Review and Meta-Analysis
- (2011) Peter Higgins et al. Cardiovascular Therapeutics
- Relationship Between Serum Urate and Plasma Oxypurinol in the Management of Gout: Determination of Minimum Plasma Oxypurinol Concentration to Achieve a Target Serum Urate Level
- (2011) L K Stamp et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Gout, Allopurinol Use, and Heart Failure Outcomes
- (2010) George Thanassoulis ARCHIVES OF INTERNAL MEDICINE
- Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
- (2010) M. Goicoechea et al. Clinical Journal of the American Society of Nephrology
- Challenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events: The case of rosiglitazone
- (2008) Adrian V. Hernandez et al. AMERICAN HEART JOURNAL
- Impact of Oxypurinol in Patients With Symptomatic Heart Failure
- (2008) Joshua M. Hare et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now